FGL: The Association for Generic Pharmaceuticals and Biosimilars in Sweden is an industry organisation. FGL is working to ensure that laws and rules and practices in the Swedish Health Care system continue to address opportunities to offer Swedish patients safe, effective and affordable generic and biosimilar medicines. FGL wishes to contribute as the representative for the generic and biosimilar industry in dialogue with the government, parliament, authorities, the health care sector and other associations and organisations in this field. FGL is a member of the European organisation Medicines for Europe.
This web-site is mainly in Swedish.
If you would like more information about FGL, please contact the Managing Director, Kenneth Nyblom.